Insider Griffin Myers of Oak Street Health, Inc. (NYSE:OSH – Get Rating) sold 200,000 shares of the company in a trade that took place on Thursday, July 28. The stock was sold at an average price of $28.63, for a total value of $5,726,000.00. Following the sale, the insider now owns 5,054,159 shares of the company, valued at approximately $144,700,572.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, accessible via this hyperlink.
Oak Street Health stock performance
Shares of NYSE OSH traded down $0.05 during Friday’s midday session, hitting $28.95. 1,459,671 shares of the company were traded, against an average volume of 2,574,580. The company has a quick ratio of 1.79, a current ratio of 1.79 and a leverage ratio of 16.10. The company has a market capitalization of $6.98 billion, a price-earnings ratio of -14.62 and a beta of 2.21. The stock has a 50-day simple moving average of $20.37 and a 200-day simple moving average of $20.45. Oak Street Health, Inc. has a 1-year low of $13.29 and a 1-year high of $65.22.
Oak Street Health (NYSE:OSH – Get Rating) last released its results on Tuesday, May 3. The company reported ($0.43) EPS for the quarter, missing the consensus estimate of ($0.39) by ($0.04). Oak Street Health had a negative return on equity of 413.94% and a negative net margin of 26.82%. The company posted revenue of $513.80 million in the quarter, compared to analyst estimates of $506.82 million. During the same quarter last year, the company posted EPS of ($0.29). The company’s revenue increased by 73.2% year over year. On average, sell-side analysts expect Oak Street Health, Inc. to post -2.2 EPS for the current fiscal year.
Institutional investors weigh in on Oak Street Health
A number of institutional investors have recently increased or reduced their stake in OSH. Capital Research Global Investors increased its stake in Oak Street Health shares by 61.0% during the 1st quarter. Capital Research Global Investors now owns 11,852,080 shares of the company worth $318,584,000 after purchasing an additional 4,491,941 shares during the period. Maverick Capital Ltd. increased its holdings in Oak Street Health by 1,464.9% during the fourth quarter. Maverick Capital Ltd. now owns 4,225,127 shares of the company worth $140,021,000 after purchasing an additional 3,955,127 shares in the last quarter. Route One Investment Company LP increased its position in Oak Street Health by 92.9% during the first quarter. Route One Investment Company LP now owns 5,725,037 shares of the company worth $153,889,000 after purchasing an additional 2,756,500 shares during the period. Eminence Capital LP bought a new position in Oak Street Health in the first quarter, valued at around $73,233,000. Finally, Capital World Investors increased its stake in Oak Street Health by 44.5% in the fourth quarter. Capital World Investors now owns 5,966,260 shares of the company valued at $197,722,000 after purchasing an additional 1,836,533 shares last quarter. Hedge funds and other institutional investors hold 91.42% of the company’s shares.
Changes to analyst ratings
A number of research firms have looked into OSH. UBS Group assumed coverage of Oak Street Health shares in a report on Wednesday, April 20. They set a “neutral” rating and a price target of $26.00 on the stock. Barclays raised its price target on Oak Street Health shares from $27.00 to $31.00 and gave the company an “overweight” rating in a Tuesday, April 19 research report. Bank of America downgraded Oak Street Health from a “buy” rating to an “underperform” rating and lowered its price target for the stock from $26.00 to $18.00 in a Wednesday 15 report. June. Stifel Nicolaus raised his target price on Oak Street Health from $25.00 to $35.00 in a report released Wednesday. Finally, Argus began covering Oak Street Health in a research report on Tuesday. They issued a “hold” rating for the company. One research analyst rated the stock with a sell rating, five issued a hold rating and eleven assigned the company’s stock a buy rating. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $34.81.
About Oak Street Health
(Get an evaluation)
Oak Street Health, Inc, together with its subsidiaries, provides patient health services in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio and Texas.
This instant news alert was powered by MarketBeat’s storytelling science technology and financial data to provide readers with the fastest and most accurate reports. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send questions or comments about this story to [email protected]
Should you invest $1,000 in Oak Street Health right now?
Before you consider Oak Street Health, you’ll want to hear this.
MarketBeat tracks daily the highest rated and most successful research analysts on Wall Street and the stocks they recommend to their clients. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the market takes off…and Oak Street Health wasn’t on the list.
Although Oak Street Health currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
See the 5 actions here